Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Brazil

 

M42 expands in Brazil via Diaverum

Abu Dhabi-based tech-enabled healthcare conglomerate M42 has expanded its presence in Brazil by acquiring four renal clinics from São Paulo-based Lund Group. The acquisition is being done via Swedish multinational dialysis group Diaverum, which M42 has owned since 2023.
April 30, 2026

DaVita to become largest dialysis services provider in Latin America

Kidney dialysis services provider DaVita is going to become the largest dialysis services provider in Latin America following agreements with Fresenius Medical Care, a rival multinational group, to expand in Brazil and Colombia and enter Chile and Ecuador for the first time.
March 15, 2024

Eugin sells for €500m

Healthcare conglomerate Fresenius has sold Eugin, its Spain-based fertility business, to KKR-owned fertility group IVI RMA and Spain-based asset management firm GED for €500m including earn-outs.
November 10, 2023

Bankruptcies, closures, and scandals: the bleak state of European nursing homes

Across Europe, nursing homes are in crisis. Between scandals in France, insolvencies in Germany, the threat of regulation in Spain, and fair fee woes in the UK, HBI hears that the nursing home sector is the least attractive healthcare services sector for investors. Are things really that bad - and is the threat of mass bankruptcies real?
October 27, 2023

Germany cuts red tape to recruit outside EU

This summer, a new immigration reform was passed to make it easier for workers from non-EU countries to relocate to Germany. An Indian organisation plans to train 2,000 nurses for the German market. HBI speaks to experts to find out who will make the most of the changes and if it’s the best course of action to combat labour shortages.
September 1, 2023

FREE BLOG Emerging market providers make up half the Top 50

Half the top 50 listed health care service groups globally by market cap are now headquartered in emerging markets. What does that tell us about the sector internationally?  We publish the top 50 with detailed analysis in Deals and Insights.
August 11, 2023

Mubadala-backed M42 buying Diaverum “for $2bn+”

Swedish multinational dialysis firm Diaverum is being bought by M42, a joint venture between Abu Dhabi sovereign wealth fund Mubadala Investment Co and AI firm G42, for a reported $2bn-$2.5bn. Diaverum’s CEO tells HBI the deal offers further opportunities to develop its digital strategies, and international expansion. 
April 19, 2023

Diaverum deal: An analysis

Last week the news broke that Abu Dhabi sovereign wealth fund Mubadala Investment Co might be set to buy Swedish multinational dialysis firm Diaverum for a reported $2.5bn. HBI speaks to an operator source who thinks this would be a good price for the seller - and hears why some investors are switched off by dialysis.
April 6, 2023
Older posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us